FFA
TSVT

Freedman Financial Associates’s 2seventy bio TSVT Stock Holding History

Freedman Financial Associates’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-166
Closed -$3K – 384
2022
Q1 		$3K Hold
166
– – ﹤0.01% 445
2021
Q4 		$4K Buy
+166
New +$5.18K ﹤0.01% 403

Other funds holding TSVT

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Freedman Financial Associates's TSVT Position: Q2 2022 in Review

Freedman Financial Associates sold out of 2seventy bio (TSVT) in Q2 2022, closing a stake of 166 shares — an estimated $3K sold.

Freedman Financial Associates first reported a position in TSVT in Q4 2021 and held it in 2 quarters. The position peaked at $4K in Q4 2021. 132 funds tracked by Wall St. Rank hold TSVT as of Q2 2022.

  • Freedman Financial Associates reported no remaining 2seventy bio position as of Q2 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 166 2seventy bio shares in Q2 2022, an estimated $3K.
  • Freedman Financial Associates first reported a position in 2seventy bio in Q4 2021 and held it in 2 quarters.
  • Freedman Financial Associates's 2seventy bio position peaked at $4K in Q4 2021.
  • 132 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.